The Mount Sinai Health System in New York City announced Monday, Sept. 23, the creation of its new BioMedical Engineering and Imaging Institute (BMEII).
The center, expected to be fully operational by early 2020, will focus on using Mount Sinai’s data for the development of new solutions related to medical imaging, nanomedicine, AI, robotics, sensors and more. At least nine researchers and their teams will be invited to work within the BMEII.
The new center will focus its attention on three key areas:
- How AI can help radiologists provide more efficient, accurate diagnoses
- The development of new medical devices that lead to better patient outcomes
- The use of virtual reality, augmented reality and extended reality in healthcare
“Our imaging and nanomedicine programs are leaders in the development and application of these novel technologies to improve patients’ diagnosis and treatment,” Zahi Fayad, PhD, Director of the BMEII, said in a prepared statement. “By integrating artificial intelligence, sensors, robotics, and virtual reality into our programs, the BMEII will take a transformative leap forward in the implementation of next generation medicine and healthcare for our patients and society.”
“Mount Sinai has consistently been at the forefront of advancing health care, and the BMEII will revolutionize how we use technology to treat a wide range of conditions,” Dennis S. Charney, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine and president for academic affairs for the Mount Sinai Health System, said in the same statement. “This is a unique endeavor that will create a hub for world-class researchers and innovators, and position us to find groundbreaking solutions for treating disease.”